Bob Ozelie has a strong background in finance and has held various leadership roles in different companies, including Cardinal Health, TIDI Products, LLC, and Genpact. Bob currently serves as the Chief Financial Officer at Kreg Therapeutics. Ozelie has expertise in areas such as FP&A, data management, pricing, and commercial strategy, and has shown proficiency in leading finance organizations and creating processes to support business initiatives. Bob holds a Bachelor's degree in Finance from Indiana University - Kelley School of Business.
February, 2023 - present
Chief Financial Officer at Global Ferronickel Holdings Inc
Chief Financial Officer at Asiamet Resources
Chief Financial Officer at Off Duty Management
Chief Financial Officer at Watchful
Chief Financial Officer at Advantis Medical Staffing